Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Möbs

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|December 23, 2016
[Diagnostics of drug hypersensitivity reactions]C Möbs, W Pfützner
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|December 6, 2018
[Personalized medicine in allergology]W Pfützner, J Pickert, C Möbs
Journal of the European Academy of Dermatology and Venereology : JEADV|January 19, 2020
Omalizumab response correlates with reduced IFN-γ-, IL-10- and IL-31-secreting cells in chronic spontaneous urticariaM M Rauber, J Pickert, L Holiangu, et al.
Allergy|June 7, 2017
Functional and phenotypic analysis of basophils allows determining distinct subtypes in patients with chronic urticariaM M Rauber, J Pickert, L Holiangu, et al.
The British Journal of Dermatology|November 19, 2011
Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult-to-treat pemphigus vulgarisM Behzad, C Möbs, A Kneisel, et al.
International Journal of Pharmaceutics|September 9, 2018
Development of a skin-friendly microemulsion for dermal allergen-specific immunotherapyC Kiselmann, D Dobler, T Schmidts, et al.
Allergy|March 11, 2015
Decline of Ves v 5-specific blocking capacity in wasp venom-allergic patients after stopping allergen immunotherapyC Möbs, J Müller, A Rudzio, et al.
Allergy|November 25, 2017
Immunological differences between insect venom-allergic patients with and without immunotherapy and asymptomatically sensitized subjectsL Arzt, D Bokanovic, C Schrautzer, et al.
Allergy|September 24, 2013
Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollenB Subbarayal, D Schiller, C Möbs, et al.
Allergy|November 22, 2017
Blocking antibodies induced by allergen-specific immunotherapy ameliorate allergic airway disease in a human/mouse chimeric modelC Vizzardelli, M Gindl, S Roos, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|December 23, 2016
[Diagnostics of drug hypersensitivity reactions]C Möbs, W Pfützner
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|December 6, 2018
[Personalized medicine in allergology]W Pfützner, J Pickert, C Möbs
Journal of the European Academy of Dermatology and Venereology : JEADV|January 19, 2020
Omalizumab response correlates with reduced IFN-γ-, IL-10- and IL-31-secreting cells in chronic spontaneous urticariaM M Rauber, J Pickert, L Holiangu, et al.
Allergy|June 7, 2017
Functional and phenotypic analysis of basophils allows determining distinct subtypes in patients with chronic urticariaM M Rauber, J Pickert, L Holiangu, et al.
The British Journal of Dermatology|November 19, 2011
Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult-to-treat pemphigus vulgarisM Behzad, C Möbs, A Kneisel, et al.
International Journal of Pharmaceutics|September 9, 2018
Development of a skin-friendly microemulsion for dermal allergen-specific immunotherapyC Kiselmann, D Dobler, T Schmidts, et al.
Allergy|March 11, 2015
Decline of Ves v 5-specific blocking capacity in wasp venom-allergic patients after stopping allergen immunotherapyC Möbs, J Müller, A Rudzio, et al.
Allergy|November 25, 2017
Immunological differences between insect venom-allergic patients with and without immunotherapy and asymptomatically sensitized subjectsL Arzt, D Bokanovic, C Schrautzer, et al.
Allergy|September 24, 2013
Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollenB Subbarayal, D Schiller, C Möbs, et al.
Allergy|November 22, 2017
Blocking antibodies induced by allergen-specific immunotherapy ameliorate allergic airway disease in a human/mouse chimeric modelC Vizzardelli, M Gindl, S Roos, et al.
Pageof 2